CollPlant Regains Nasdaq $1.00 Minimum Bid Price Compliance; CLGN Stock Rises

CollPlant Biotechnologies Ltd. (CLGN) said on September 22, 2026, that it received formal notification from Nasdaq confirming it has regained compliance with the exchange's $1.00 per share minimum bid price requirement. The regenerative and aesthetic medicine company's shares rose following the announcement. Nasdaq rules require listed companies to maintain a closing bid price of at least $1.00 per share. Failure to do so for 30 consecutive business days triggers a deficiency notice and a 180-day period to regain compliance. The notification removes the immediate threat of delisting over the bid price issue. CollPlant did not disclose the specific closing bid price or the date on which compliance was restored.